Data on AstraZeneca vaccine insufficient for Swiss approval
Last week Swissmedic received a large package of data from the pharmaceutical company, which it is now reviewing.
Copyright 2021 The Associated Press. All Rights Reserved
This content was published on
2 minutes
Keystone-SDA/gw
Español
es
Los datos de AstraZeneca son insuficientes para aprobación en Suiza
The medicines regulator Swissmedic says it has not yet received enough robust data from clinical trials to give the green light to the Covid-19 vaccine developed by the Swedish-British company.
While the supervisory authority saw conclusive results from studies involving many participants to approve two other coronavirus vaccines, the same could not be said for the Oxford-AstraZeneca shot, Swissmedic director Raimund Bruhin told the CH Media group of newspapers on Thursday.
But this did not mean that he believes the vaccine is a poor one.
“We are only saying that the company has not yet been able to prove to us that it is a good vaccine,” said Bruhin.
The approvals process, he added, was about hard data and facts. Last week Swissmedic received a large package of data from the pharmaceutical company, which it is now reviewing, and remains in regular contact with the makers of the vaccine.
Other countries, such as the United Kingdom, have been administering the AstraZeneca vaccine for over three months – although several nations have halted vaccinations in recent days over isolated cases of blood-clotting. The European Medicines Agency has said the benefits of the Oxford-AstraZeneca jab greatly outweigh the risks and on Thursday will issue a report on its investigation into cases of blood clots.
Switzerland has ordered more than 35 million doses of Covid-19 vaccines from five manufacturers. To date Swissmedic has approved shots developed by Pfizer/BioNTech and Moderna. Roughly 4% of the population has been vaccinated so far, but delays in approval and delivery have slowed the roll-out process.
Popular Stories
More
Workplace Switzerland
Meet the foreigners who make up a quarter of the Swiss population
Bodycams: essential for good law enforcement, or a privacy risk?
Did you ever come across bodycams in your place of residence and if so, how do you think the use of bodycams alter the relationship between the public and (transport) police?
What do you think Switzerland’s Alain Berset can bring to the Council of Europe?
The former interior minister is to become the first Swiss Secretary General of the Council of Europe – which issues should his five-year term focus on?
Swiss signatures scam: firms also acted without a mandate, authorities say
This content was published on
Some professional signature-gathering firms acted without a mandate, before pressuring committees to accept names, the Federal Chancellery says.
Swiss researchers find new highest peak in Jura mountain range
This content was published on
The Crêt de la Neige, a French peak not far from Geneva, has lost its title as the highest in the Jura to the newly-discovered “J1”.
Fatal household accidents on the rise in Switzerland
This content was published on
More and more people are dying in accidents, with suffocations and fatal falls rising notably in the last decade, new statistics show.
Swiss health insurers: premiums could rise by 5% in 2025
This content was published on
The association of Swiss health insurers, Santésuisse, expects another hefty hike in premiums next year as costs keep growing.
Parliament gets closer to finalising new digital ID scheme
This content was published on
Both chambers of the Swiss parliament have now approved the legal basis and credit for the latest attempt at an electronic proof of identity.
Majority of Swiss against immigration ban, survey finds
This content was published on
While almost two-thirds of Swiss are worried about the population reaching 10 million, three out of five are against a ban on immigration.
Tariq Ramadan convicted of rape by Swiss appeals court
This content was published on
A Swiss court has overturned the acquittal of the prominent Islamic scholar on charges of rape and sexual coercion against a woman.
UBS weighs wealth tie-up to compete in Indian market
This content was published on
The Swiss bank is exploring various wealth management partnership options in India, where competition is intense, Bloomberg reports.
This content was published on
On Monday, one of the two chambers of parliament in Bern voted to immediately stop payments to the UN agency for Palestinian refugees.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
Switzerland could sell or give away AstraZeneca doses if regulator dithers
This content was published on
A lack of green light from medicines regulator Swissmedic could see 5.3 million doses ordered by Switzerland sent elsewhere.
This content was published on
Media reports indicate that vaccinating everyone who wants to by summer relies on meeting ambitious vaccine delivery targets in spring.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.